Eosinophilic pneumonia caused by mesalazine. Report of one case

A 50 years old male with a diagnosis of ulcerative colitis treated with mesalazine, developed after 2 months of treatment, cough, fever and progressive dyspnea. Chest X ray examination and CT scan showed pulmonary infiltrates in the right upper lobe that subsequently involved both lower lobes. A bio...

Full description

Saved in:
Bibliographic Details
Published in:Revista medíca de Chile 2003-01, Vol.131 (1), p.81
Main Authors: Pérez, Carlos, Errázuriz, Isabel, Brockmann, Pablo, González, Sergio, Cofré, Cecilia
Format: Article
Language:Spanish
Subjects:
Anti-Inflammatory Agents - therapeutic use
Anti-Inflammatory Agents, Non-Steroidal - adverse effects
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Colitis, Ulcerative - drug therapy
Humans
Hydrocortisone - therapeutic use
Male
Mesalamine - adverse effects
Mesalamine - therapeutic use
Middle Aged
Prednisone - therapeutic use
Pulmonary Eosinophilia - chemically induced
Pulmonary Eosinophilia - diagnosis
Pulmonary Eosinophilia - drug therapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 1
container_start_page 81
container_title Revista medíca de Chile
container_volume 131
creator Pérez, Carlos
Errázuriz, Isabel
Brockmann, Pablo
González, Sergio
Cofré, Cecilia
description A 50 years old male with a diagnosis of ulcerative colitis treated with mesalazine, developed after 2 months of treatment, cough, fever and progressive dyspnea. Chest X ray examination and CT scan showed pulmonary infiltrates in the right upper lobe that subsequently involved both lower lobes. A biopsy, made through videothoracoscopy, showed an eosinophilic pneumonia. After the discontinuation of mesalazine and the use of glucocorticoids, the respiratory involvement resolved, and pulmonary infiltrates regressed. Mesalazine is widely used in the treatment of inflammatory bowel diseases. Pulmonary toxicity is an uncommon complication of mesalazine treatment. Nevertheless, this complication should be considered in patients that use it and develop respiratory symptoms.
format article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_12643224</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>12643224</sourcerecordid><originalsourceid>FETCH-LOGICAL-p139t-87e838e57ec809576230f8ebe23c3febd62f7e778d415b7d0f3b2e70f4cfccc53</originalsourceid><addsrcrecordid>eNo1j8tKxDAUQLNQnHH0FyQ_UElz0950JTKMDxgQRNdDHjcYaZPQTBfj1yuoq7M5HDhnbC0EqGbQGlfsstZPIST2rb5gq1b2CqRUa3a3yzWmXD7iGB0viZYpp2i4M0slz-2JT1TNaL5iolv-SiXPR54Dz4l-nEpX7DyYsdL1Hzfs_WH3tn1q9i-Pz9v7fVNaGI6NRtKgqUNyWgwd9hJE0GRJgoNA1vcyICFqr9rOohcBrCQUQbngnOtgw25-u2WxE_lDmeNk5tPh_wS-AS6dRFk</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Eosinophilic pneumonia caused by mesalazine. Report of one case</title><source>SciELO Chile</source><creator>Pérez, Carlos ; Errázuriz, Isabel ; Brockmann, Pablo ; González, Sergio ; Cofré, Cecilia</creator><creatorcontrib>Pérez, Carlos ; Errázuriz, Isabel ; Brockmann, Pablo ; González, Sergio ; Cofré, Cecilia</creatorcontrib><description>A 50 years old male with a diagnosis of ulcerative colitis treated with mesalazine, developed after 2 months of treatment, cough, fever and progressive dyspnea. Chest X ray examination and CT scan showed pulmonary infiltrates in the right upper lobe that subsequently involved both lower lobes. A biopsy, made through videothoracoscopy, showed an eosinophilic pneumonia. After the discontinuation of mesalazine and the use of glucocorticoids, the respiratory involvement resolved, and pulmonary infiltrates regressed. Mesalazine is widely used in the treatment of inflammatory bowel diseases. Pulmonary toxicity is an uncommon complication of mesalazine treatment. Nevertheless, this complication should be considered in patients that use it and develop respiratory symptoms.</description><identifier>ISSN: 0034-9887</identifier><identifier>PMID: 12643224</identifier><language>spa</language><publisher>Chile</publisher><subject>Anti-Inflammatory Agents - therapeutic use ; Anti-Inflammatory Agents, Non-Steroidal - adverse effects ; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Colitis, Ulcerative - drug therapy ; Humans ; Hydrocortisone - therapeutic use ; Male ; Mesalamine - adverse effects ; Mesalamine - therapeutic use ; Middle Aged ; Prednisone - therapeutic use ; Pulmonary Eosinophilia - chemically induced ; Pulmonary Eosinophilia - diagnosis ; Pulmonary Eosinophilia - drug therapy</subject><ispartof>Revista medíca de Chile, 2003-01, Vol.131 (1), p.81</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12643224$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pérez, Carlos</creatorcontrib><creatorcontrib>Errázuriz, Isabel</creatorcontrib><creatorcontrib>Brockmann, Pablo</creatorcontrib><creatorcontrib>González, Sergio</creatorcontrib><creatorcontrib>Cofré, Cecilia</creatorcontrib><title>Eosinophilic pneumonia caused by mesalazine. Report of one case</title><title>Revista medíca de Chile</title><addtitle>Rev Med Chil</addtitle><description>A 50 years old male with a diagnosis of ulcerative colitis treated with mesalazine, developed after 2 months of treatment, cough, fever and progressive dyspnea. Chest X ray examination and CT scan showed pulmonary infiltrates in the right upper lobe that subsequently involved both lower lobes. A biopsy, made through videothoracoscopy, showed an eosinophilic pneumonia. After the discontinuation of mesalazine and the use of glucocorticoids, the respiratory involvement resolved, and pulmonary infiltrates regressed. Mesalazine is widely used in the treatment of inflammatory bowel diseases. Pulmonary toxicity is an uncommon complication of mesalazine treatment. Nevertheless, this complication should be considered in patients that use it and develop respiratory symptoms.</description><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - adverse effects</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Colitis, Ulcerative - drug therapy</subject><subject>Humans</subject><subject>Hydrocortisone - therapeutic use</subject><subject>Male</subject><subject>Mesalamine - adverse effects</subject><subject>Mesalamine - therapeutic use</subject><subject>Middle Aged</subject><subject>Prednisone - therapeutic use</subject><subject>Pulmonary Eosinophilia - chemically induced</subject><subject>Pulmonary Eosinophilia - diagnosis</subject><subject>Pulmonary Eosinophilia - drug therapy</subject><issn>0034-9887</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNo1j8tKxDAUQLNQnHH0FyQ_UElz0950JTKMDxgQRNdDHjcYaZPQTBfj1yuoq7M5HDhnbC0EqGbQGlfsstZPIST2rb5gq1b2CqRUa3a3yzWmXD7iGB0viZYpp2i4M0slz-2JT1TNaL5iolv-SiXPR54Dz4l-nEpX7DyYsdL1Hzfs_WH3tn1q9i-Pz9v7fVNaGI6NRtKgqUNyWgwd9hJE0GRJgoNA1vcyICFqr9rOohcBrCQUQbngnOtgw25-u2WxE_lDmeNk5tPh_wS-AS6dRFk</recordid><startdate>200301</startdate><enddate>200301</enddate><creator>Pérez, Carlos</creator><creator>Errázuriz, Isabel</creator><creator>Brockmann, Pablo</creator><creator>González, Sergio</creator><creator>Cofré, Cecilia</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>200301</creationdate><title>Eosinophilic pneumonia caused by mesalazine. Report of one case</title><author>Pérez, Carlos ; Errázuriz, Isabel ; Brockmann, Pablo ; González, Sergio ; Cofré, Cecilia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p139t-87e838e57ec809576230f8ebe23c3febd62f7e778d415b7d0f3b2e70f4cfccc53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>spa</language><creationdate>2003</creationdate><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - adverse effects</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Colitis, Ulcerative - drug therapy</topic><topic>Humans</topic><topic>Hydrocortisone - therapeutic use</topic><topic>Male</topic><topic>Mesalamine - adverse effects</topic><topic>Mesalamine - therapeutic use</topic><topic>Middle Aged</topic><topic>Prednisone - therapeutic use</topic><topic>Pulmonary Eosinophilia - chemically induced</topic><topic>Pulmonary Eosinophilia - diagnosis</topic><topic>Pulmonary Eosinophilia - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pérez, Carlos</creatorcontrib><creatorcontrib>Errázuriz, Isabel</creatorcontrib><creatorcontrib>Brockmann, Pablo</creatorcontrib><creatorcontrib>González, Sergio</creatorcontrib><creatorcontrib>Cofré, Cecilia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Revista medíca de Chile</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pérez, Carlos</au><au>Errázuriz, Isabel</au><au>Brockmann, Pablo</au><au>González, Sergio</au><au>Cofré, Cecilia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Eosinophilic pneumonia caused by mesalazine. Report of one case</atitle><jtitle>Revista medíca de Chile</jtitle><addtitle>Rev Med Chil</addtitle><date>2003-01</date><risdate>2003</risdate><volume>131</volume><issue>1</issue><spage>81</spage><pages>81-</pages><issn>0034-9887</issn><abstract>A 50 years old male with a diagnosis of ulcerative colitis treated with mesalazine, developed after 2 months of treatment, cough, fever and progressive dyspnea. Chest X ray examination and CT scan showed pulmonary infiltrates in the right upper lobe that subsequently involved both lower lobes. A biopsy, made through videothoracoscopy, showed an eosinophilic pneumonia. After the discontinuation of mesalazine and the use of glucocorticoids, the respiratory involvement resolved, and pulmonary infiltrates regressed. Mesalazine is widely used in the treatment of inflammatory bowel diseases. Pulmonary toxicity is an uncommon complication of mesalazine treatment. Nevertheless, this complication should be considered in patients that use it and develop respiratory symptoms.</abstract><cop>Chile</cop><pmid>12643224</pmid></addata></record>
fulltext fulltext
identifier ISSN: 0034-9887
ispartof Revista medíca de Chile, 2003-01, Vol.131 (1), p.81
issn 0034-9887
language spa
recordid cdi_pubmed_primary_12643224
source SciELO Chile
subjects Anti-Inflammatory Agents - therapeutic use
Anti-Inflammatory Agents, Non-Steroidal - adverse effects
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Colitis, Ulcerative - drug therapy
Humans
Hydrocortisone - therapeutic use
Male
Mesalamine - adverse effects
Mesalamine - therapeutic use
Middle Aged
Prednisone - therapeutic use
Pulmonary Eosinophilia - chemically induced
Pulmonary Eosinophilia - diagnosis
Pulmonary Eosinophilia - drug therapy
title Eosinophilic pneumonia caused by mesalazine. Report of one case
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T19%3A38%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Eosinophilic%20pneumonia%20caused%20by%20mesalazine.%20Report%20of%20one%20case&rft.jtitle=Revista%20med%C3%ADca%20de%20Chile&rft.au=P%C3%A9rez,%20Carlos&rft.date=2003-01&rft.volume=131&rft.issue=1&rft.spage=81&rft.pages=81-&rft.issn=0034-9887&rft_id=info:doi/&rft_dat=%3Cpubmed%3E12643224%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p139t-87e838e57ec809576230f8ebe23c3febd62f7e778d415b7d0f3b2e70f4cfccc53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/12643224&rfr_iscdi=true